Support the research and development of vaccines and medicines for the communicable and non‑communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all
Updated Tier Classification (by IAEG-SDG Members – as of 11 May 2018): Tier II
Updated Tier Classification (by IAEG-SDG Members – as of 26 Sep 20I9): Tier I
Notes (including timing of review and explanation for change in Tier): Data availability reviewed in Nov. 2018
(classified as Tier I)
Reviewed at Webex meeting in Nov. 2017
following 6th IAEG-SDG meeting (classified
as Tier II)
UNSC 48 Refinement; Reviewed at 5th IAEGSDG
meeting (classified as Tier III)
Metadata: https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf
DATA AVAILABILITY [choose option]: The exact SDG indicator can be calculated
Additional information: The indicator is calaculted for children age 0-35 months
Source:
{“title”:””,”url”:”https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf”,”target”:””}